title: Improve-it: Full disclosures?
authors: General practice in private office, 75 Avenue Léon Blum, 87350 Panazol, France. Electronic address: nicotphi@club-internet.fr.
authors: Philippe
authors: P
authors: Nicot
authors: Centre Hospitalier Universitaire de Grenoble, Department of Cardiology, BP 217, 38043 Grenoble Cedex 09, France.
authors: Raphaelle-Ashley
authors: RA
authors: Guerbaai
authors: Centre Hospitalier Universitaire de Grenoble, Department of Cardiology, BP 217, 38043 Grenoble Cedex 09, France.
authors: Pierre-Vladimir
authors: PV
authors: Ennezat
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D030881:Disclosure; D004359:Drug Therapy, Combination / Q000379:methods; D000069438:Ezetimibe / Q000008:administration & dosage; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D015201:Meta-Analysis as Topic; D019821:Simvastatin / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin; D000069438:Ezetimibe
keywords: Critical reappraisal; New-onset diabetes; Statin